{"id":"doi:10.1016/j.molmet.2021.101351","kind":"review","title":"GLP-1 physiology informs the pharmacotherapy of obesity","authors":["Daniel J. Drucker"],"author_count":1,"year":2021,"published":"2021-10-08","venue":"Molecular Metabolism","cited_by":508,"doi":"10.1016/j.molmet.2021.101351","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.molmet.2021.101351","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.molmet.2021.101351","updated":null,"pmid":"34626851","pmcid":null,"openalex_id":"W3202781181","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2212877821001988/pdf","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Regulation of Appetite and Obesity"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}